For example, the EVOKE and EVOKE+ studies are exploring whether semaglutide slows Alzheimers progression in individuals without diabetes
As my prior example shows, this isn't theoretical it's happening now with real clients
Indeed, the potential promise of GLP-1(2836) as a synthetic peptide that enables GLP-1Rindependent, MTP-dependent, sAC-mediated cytoprotective cAMP signaling, with no effect on HR, is worthy of further exploration
Potential Risks and Side Effects of Combining Tirzepatide with Cannabis While direct pharmacological interactions may be minimal, combining tirzepatide with cannabis carries several indirect risks that warrant careful consideration
Morgan Stanley also said in the survey that GLP-1s are a manageable long-term pressure on restaurants, not an "existential risk." "Restaurants offer convenience and/or experience in addition to food, and that won't change with GLP-1 usage," the analysts said